Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03948971 · ClinicalTrials.gov registry record · NA

Prospective Measurement of Normal Venous Sinus Pressures

A NA study of Intracranial Venous Pressures, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03948971 is a NA study of Intracranial Venous Pressures that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03948971, a NA study of Intracranial Venous Pressures, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not require any extra visits. The intervention will take place in the interventional radiology suite when the subject has an angiogram. IIH is a condition that causes increased pressure in the brain in the absence of a tumor or other diseases that may be causing symptoms. Symptoms include headaches and visual disturbances not explained by other things. In IIH there is a narrowing in the sinuses of the brain that causes the increased pressure.

Interventions

  • PROCEDURE Venogram

Study Locations (1)

North Carolina

  • Wake Forest Univesity Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-01-13
Est. Completion 2026-05
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT03948971

The ClinicalTrials.gov registry entry for NCT03948971 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracranial Venous Pressures appearing as the primary indexed condition, and to 1 intervention - of which Venogram is the first listed.

NCT03948971 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03948971 about?

NCT03948971 is a clinical study titled "Prospective Measurement of Normal Venous Sinus Pressures". The purpose of this research is to document normal intracranial venous sinus pressures. Participants who need to have a cerebral angiogram to evaluate a medical problem not related to Idiopathic Intracranial Hypertension (IIH) will be invited to participate. Participation in this research will not r...

What is the current status of trial NCT03948971?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-13. Estimated completion is 2026-05.

What conditions does trial NCT03948971 study?

This clinical trial studies the following conditions: Intracranial Venous Pressures.

What interventions are being tested in trial NCT03948971?

The interventions under investigation include: Venogram (PROCEDURE).

Who is sponsoring clinical trial NCT03948971?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03948971 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.